title: Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma - authors' reply.
authors: Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA. iym4@cdc.gov.
authors: P P
authors: PP
authors: Gounder
authors: Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA.
authors: L R
authors: LR
authors: Bulkow
authors: Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA.|Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA.
authors: B J
authors: BJ
authors: McMahon
mesh_terms: D006528:Carcinoma, Hepatocellular; D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens; D006515:Hepatitis B virus / Q000235:genetics; D019694:Hepatitis B, Chronic; D006801:Humans; D008113:Liver Neoplasms
chemical_list: D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens